Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1247446A vs Fluarix in adults 18-59
NCT00374842Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Primary completion
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK1247446A in influenza, sponsored by GSK. Primary endpoint: Serum Haemagglutination-inhibition Antibody Titers at 21 days. Started Oct 2006; status: completed.
02
Drugs
GSK1247446A
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00374842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374842.